Figure 6 
TREATMENT AND MONITORING SCHEDULES 
Treatment or Day of Study* 
Evaluation 
0 14 28 42 60 90 120 210 300 390 Yearly 
Serum IL-2 
Humoral Immunity 
10 cc Red Top 
Immunophenotyping 
Cellular Immunity 
Skin Testing 
50 cc Green 
Top 
* The two week evaluations may be delayed up to 72 hours and the 3 month evaluations may be delayed 
by one week if necessary due to logistical/patient convenience issues. 
Recombinant DNA Research, Volume 19 
[623] 
